JBM  Vol.7 No.1 , January 2019
The Possible Role Serum Biochemical Analysis Can Play in Predicting an Infant’s Risk of Retinopathy of Prematurity; Elevated Serum Magnesium
Abstract: Purpose: We evaluated biochemical analysis results with the aim of discovering serum levels that have possible effects on the development of retinopathy of prematurity (ROP). Methods: A retrospective study was conducted between January 2017 and January 2018 on a total of 110 infants with 35 or less gestational weeks. The sample included 78 infants who had been diagnosed with different stages of ROP and 32 infants without ROP. Results from routine serum biochemical analyses, performed at birth and at one month after birth, were evaluated. The Independent Sample t-test and Mann-Whitney U test were performed to compare the data. Results: The infants with ROP were born at a mean of 28.0 (±2.1) weeks of gestation, weighing a mean of 1066 (±314) g, and the mean duration of stay in the incubator was 38.2 (±19) days. The infants without ROP were born at a mean of 29.6 (±2.6) weeks of gestation, weighing a mean of 1265 (±372) g. 59 infants (53.6%) were females, and 51 (46.4%) were males. Between infants with and without ROP, differences in the following levels were not statistically significant: glucose, blood urine nitrogen, creatinine, alanine aminotransferase, aspartate aminotransferase, albumin, total protein, direct bilirubin, indirect bilirubin, uric acid, and phosphorus. Serum magnesium (Mg) levels at birth in infants with ROP were significantly higher than infants without ROP (p = 0.014). Conclusions: Serum Mg levels at birth were found to be higher in infants with ROP than in those without ROP. The levels may be dependent on the mothers’ treatment of Mg for different medical reasons.
Cite this paper: Akdogan, M. , Sabaner, M. , Ustundag, Y. , Dogan, M. and Varal, I. (2019) The Possible Role Serum Biochemical Analysis Can Play in Predicting an Infant’s Risk of Retinopathy of Prematurity; Elevated Serum Magnesium. Journal of Biosciences and Medicines, 7, 71-82. doi: 10.4236/jbm.2019.71007.

[1]   Yang, M.B. (2016) Retinopathy of Prematurity. In: Traboulsi, E. and Utz, V., Eds., Practical Management of Pediatric Ocular Disorders and Strabismus: A Case-Based Approach, 299-305.

[2]   Husain, S.M., Sinha, A.K., Bunce, C., Arora, P., Lopez, W., Mun, K.S., et al. (2013) Relationships between Maternal Ethnicity, Gestational Age, Birth Weight, Weight Gain, and Severe Retinopathy of Prematurity. Journal of Pediatrics, 163, 67-72.

[3]   Woo, S.J., Park, K.H., Ahn, J., Oh, K.J., Lee, S.Y., Jeong, E.H., et al. (2011) A Co-Twin Study of the Relative Effect of Birth Weight and Gestational Age on Retinopathy of Prematurity. Eye, 25, 1478-1483.

[4]   Esen, E., Erdem, E., Yar, K., Demircan, N. and Soylu, M. (2014) Results of Screening for Retinopathy of Prematurity: How the Ideal Screening Program Should Be? Türk Oftalmoloji Dergisi, 44, 42-46.

[5]   Bas, A.Y., Koc, E., Dilmen, U., Oguz, S.S., Ovali, F., Demirel, N., et al. (2015) Incidence and Severity of Retinopathy of Prematurity in Turkey. British Journal of Ophthalmology [Internet]. 99, 1311-1314.

[6]   Hartnett, M.E. and Penn, J.S. (2012) Mechanisms and Management of Retinopathy of Prematurity. New England Journal of Medicine, 367, 2515-2526.

[7]   Chirico, G., Di Stefano, G., Romeo, M.G., Scuderi, A., Di Pietro, M., Pisano, F., et al. (1997) Italian Multicentre Study on Retinopathy of Prematurity. European Journal of Pediatrics, 156, 939-943.

[8]   Akdogan, M., Demirag, D., Varal, I., Cevik, S. and Ustundag, Y. (2018) Haemogram Parameters in the Development of Retinopathy of Prematurity. Open Journal of Ophthalmology, 8, 75-83.

[9]   Jain, A., Aggarwal, R., Jeeva Sankar, M., Agarwal, R., Deorari, A.K. and Paul, V.K. (2010) Hypoglycemia in the Newborn. Indian Journal of Pediatrics, 77, 1137-1142.

[10]   Rozance, P.J. (2014) Update on Neonatal Hypoglycemia. Current Opinion in Endocrinology, Diabetes and Obesity, 21, 45-50.

[11]   Sharon, P., Melinda, B. and Donna, G. (2013) Breastfeeding the Preterm Infant. In: Patole, S., Ed., Nutrition for the Preterm Neonate: A Clinical Perspective, Springer, Dordrecht, 337-365.

[12]   Ambalavanan, N. and Carlo, W.A. (2016) Jaundice and Hyperbilirubinemia in the Newborn. In: Behrman, R.E., Kliegman, R.M. and Jenson, H.B., Eds., Nelson Textbook of Pediatrics, Saunders, Philadelphia, 871.

[13]   Weinberger, B., Watorek, K., Strauss, R., Witz, G., Hiatt, M. and Hegyi, T. (2002) Association of Lipid Peroxidation with Hepatocellular Injury in Preterm Infants. Critical Care, 6, 521-525.

[14]   Kosger, P., Ozer, E. and Helvaci, M. (2016) Preterm bebeklerde total parenteral beslenme ile iliskili komplikasyonlarin sikligi ve risk faktorleri. Journal of Pediatric Research, 3, 149-153.

[15]   Drenser, K.A., Trese, M.T. and Capone, A. (2010) Aggressive Posterior Retinopathy of Prematurity. Retina, 30, S37-S40.

[16]   Wilkinson, A.R., Haines, L., Head, K. and Fielder. A.R. (2008) UK Retinopathy of Prematurity Guideline. Early Human Development, 84, 71-74.

[17]   Shah, P.K. (2016) Retinopathy of Prematurity: Past, Present and Future. World Journal of Clinical Pediatrics, 5, 35-46.

[18]   Good, W.V., Hardy, R.J., Dobson, V., Palmer, E.A., Phelps, D.L., Quintos, M., et al. (2003) Revised Indications for the Treatment of Retinopathy of Prematurity: Results of the Early Treatment for Retinopathy of Prematurity Randomized Trial. Archives of Ophthalmology, 121, 1684-1696.

[19]   The Early Treatment for Retinopathy of Prematurity Cooperative Group (2004) Final Results of the Early Treatment for Retinopathy of Prematurity (ETROP) Randomized Trial. Transactions of the American Ophthalmological Society, 102, 233-250, Discussion 248-250.

[20]   Tasman, W. (2011) Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity. The New England Journal of Medicine, 364, 603-615.

[21]   Ha, M.-H. (2010) Bevacizumab Eliminates the Angiogenic Threat of Retinopathy of Prematurity (BEAT-ROP).

[22]   Bauer, J. and Gerss, J. (2011) Longitudinal Analysis of Macronutrients and Minerals in Human Milk Produced by Mothers of Preterm Infants. Clinical Nutrition, 30, 215-220.

[23]   Basu, S.K., Chickajajur, V., Lopez, V., Bhutada, A., Pagala, M. and Rastogi, S. (2012) Immediate Clinical Outcomes in Preterm Neonates Receiving Antenatal Magnesium for Neuroprotection. Journal of Perinatal Medicine, 40, 185-189.

[24]   Grimes, D.A. and Nanda, K. (2006) Magnesium Sulfate Tocolysis: Time to Quit. Obstetrics and Gynecology, 108, 986-989.

[25]   Mittendorf, R., Covert, R., Boman, J., Khoshnood, B., Lee, K.S. and Siegler, M. (1997) Is Tocolytic Magnesium Sulphate Associated with Increased Total Paediatric Mortality? Lancet, 350, 1517-1518.

[26]   Rouse, D.J., Hirtz, D.G., Thom, E., Varner, M.W., Spong, C.Y., Mercer, B.M., et al. (2009) A Randomized, Controlled Trial of Magnesium Sulfate for the Prevention of Cerebral Palsy. Obstetrical and Gynecological Survey, 64, 15-17.

[27]   Edwards, J.M., Edwards, L.E., Swamy, G.K. and Grotegut, C.A. (2018) Effect of Cord Blood Magnesium Level at Birth on Non-Neurologic Neonatal Outcomes. American Journal of Perinatology, 27.

[28]   Caddell, J.L. (1995) Hypothesis: The Possible Role of Magnesium and Copper Deficiency in Retinopathy of Prematurity. Magnesium Research, 8, 261-270.

[29]   Wallenstein, M.B. and Bhutani, V.K. (2013) Jaundice and Kernicterus in the Moderately Preterm Infant. Clinics in Perinatology, 40, 679-688.

[30]   Watchko, J.F. (2006) Hyperbilirubinemia and Bilirubin Toxicity in the Late Preterm Infant. Clinics in Perinatology, 33, 839-852.

[31]   Gaton, D.D., Gold, J., Axer-Siegel, R., Wielunsky, E., Naor, N. and Nissenkorn, I. (1991) Evaluation of Bilirubin as Possible Protective Factor in the Prevention of Retinopathy of Prematurity. British Journal of Ophthalmology, 75, 532-534.

[32]   Milner, J.D., Aly, H.Z., Ward, L.B. and El-Mohandes, A. (2003) Does Elevated Peak Bilirubin Protect from Retinopathy of Prematurity in Very Low Birth Weight Infants. Journal of Perinatology, 23, 208-211.

[33]   Fauchère, J.C., Meier-Gibbons, F.E., Koerner, F. and Bossi, E. (1994) Retinopathy of Prematurity and Bilirubinno Clinical Evidence for a Beneficial Role of Bilirubin as a Physiological Anti-Oxidant. European Journal of Pediatrics, 153, 358-362.

[34]   Ochiai, M., Matsushita, Y., Inoue, H., Kusuda, T., Kang, D., Ichihara, K., et al. (2016) Blood Reference Intervals for Preterm Low-Birth-Weight Infants: A Multicenter Cohort Study in Japan. PLoS ONE, 11, e0161439.

[35]   Bateman, D.A., Thomas, W., Parravicini, E., Polesana, E., Locatelli, C. and Lorenz, J.M. (2015) Serum Creatinine Concentration in Very-Low-Birth-Weight Infants from Birth to 34 - 36 wk Postmen-strual Age. Pediatric Research, 77, 696-702.

[36]   Black, M.J., Sutherland, M.R., Gubhaju, L., Kent, A.L., Dahlstrom, J.E. and Moore, L. (2013) When Birth Comes Early: Effects on Nephrogenesis. Nephrology, 18, 180-182.

[37]   Gubhaju, L., Sutherland, M.R., Yoder, B.A., Zulli, A., Bertram, J.F. and Black, M.J. (2009) Is Nephrogenesis Affected by Preterm Birth? Studies in a Non-Human Primate Model. American Journal of Physiology-Renal Physiology, 297, F1668-F1677.

[38]   Kushiyama, A. (2014) Linking Uric Acid Metabolism to Diabetic Complications. World Journal of Diabetes, 5, 787-795.

[39]   Xia, J.F., Wang, Z.H. and Zhang, F.F. (2014) Association between Related Purine Metabolites and Diabetic Retinopathy in Type 2 Diabetic Patients. International Journal of Endocrinology, 2014, Article ID: 651050.

[40]   Navin, S., Krishnamurthy, N., Ashakiran, S. and Dayanand, C.D. (2013) The Association of Hypomagnesaemia, High Normal Uricaemia and Dyslipidaemia in the Patients with Diabetic Retinopathy. Journal of Clinical and Diagnostic Research, 7, 1852-1854.